2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2016-2-4-78-83939Archive categoriesRESEARCH OF PHARMACEUTICAL PRODUCTS MARKET FOR THE TREATMENT OF VIRAL CONJUNCTIVITESRESEARCH OF PHARMACEUTICAL PRODUCTS MARKET FOR THE TREATMENT OF VIRAL CONJUNCTIVITESNovikovaMarina Yu.NovikovaMarina Yu.mnovikova@bsu.edu.ruBaskakovaAlexandra V.BaskakovaAlexandra V.ZhilyakovaElena T.ZhilyakovaElena T.ezhilyakova@bsu.edu.ruNovikovOleg O.NovikovOleg O.ole9222@yandex.ru20162400

The analysis of the assortment of medicinal forms for treating viral conjunctivitis was done. The obtained statistics is presented. The most common forms of viral conjunctivitis of various etiologies were described. The most active pharmaceutical substances used for medicinal forms in the treatment are identified. The authors provide a comparative characteristic of these substances and the review of their pharmacological action. The review of the benefits of acyclovir over idoxuridine was compiled and possible side effects of these drugs were described. The major trade names of currently available drugs based on acyclovir and idoxuridine were identified. The number of medicines for the treatment of viral conjunctivitis is not enough for complex treatment of this pathology.

The analysis of the assortment of medicinal forms for treating viral conjunctivitis was done. The obtained statistics is presented. The most common forms of viral conjunctivitis of various etiologies were described. The most active pharmaceutical substances used for medicinal forms in the treatment are identified. The authors provide a comparative characteristic of these substances and the review of their pharmacological action. The review of the benefits of acyclovir over idoxuridine was compiled and possible side effects of these drugs were described. The major trade names of currently available drugs based on acyclovir and idoxuridine were identified. The number of medicines for the treatment of viral conjunctivitis is not enough for complex treatment of this pathology.

acyclovireye dropsmarket researchsolubilityacyclovireye dropsmarket researchsolubilityСписок литературы1. Antropov G.A., Okonenko T.I., Babaskin L.I. The Aspects of Selection of Ophthalmic Antibacterial Drugs at the Regional Level. Bulletin of Novgorod State University. 2015. № 2 (85) Pp. 5-10.2. Antropov G.A. Okonenko T.I. The "Red-eye" Syndrome. Problems of Self-care and Pharmaceutical Assistance: a Monograph: Novgorod: Novgorod State University, 2013. 174 p.3. Babushkin, A.E., Zaynutdinova G.H. Dynamics of Some Inflammatory Eye Diseases in the Republic of Bashkortostan in 2001-2013. Viewpoint. East - West / Ufa Research Institute of Eye Diseases, The Academy of Sciences, the Republic of Bashkortostan. 2015.  Vol. 1. Pp. 173-176.4. Babushkin A.E., Matyukhina E.N. Comparative Analysis of Herpetic Keratitis in 1974-1984 and 2011-2013. Viewpoint. East - West / Ufa Research Institute of Eye Diseases. The Academy of Sciences, the Republic of Bashkortostan. 2015. Vol. 1. Pp. 176-177. 5. Blepharitis / Polunin G., Kasparov E. Polunin E., Zabegailo A., Pimenidi M.  The Medical Newspaper. 2006. № 31. Pp. 9.6. Veretennikova M.A. Modern Herpes Pharmacotherapy Using a Variety of Dosage Forms. Basic Research. 2014. №8-7. Pp.1630-1634.7. Voskresenskaya L.K., Bezkorovainy I.N., Ryadnova V.V. The Effectiveness of Antiviral Drugs in the Treatment of Viral Conjunctivitis. The Problems of Biology and Medicine Bulletin. 2014. № 1. Pp. 76-80.8. Gaydamak T.B., Andryukova L.N., Krasichkova E.A. Determination of the Specific Activity of Eye-drops Based on Laferon ("okoferona") on the Model of Viral Keratitis.  The Journal of Ophthalmology. 2001. № 4. Pp. 62-66.9. Eye Diseases: a Textbook for Students of Medical Universities / ed. by V.G. Kopaeva. Moscow: Medicine, 2002. 559 p.10. Evstafieva K.O., Pryakhin V.V. Аnalysis of Supramolecular Structures and Reinforcing Action of Nanoparticles in Polymer Matrices. Success of Modern Science.  2012. №6. Pp.28-30.11. Eremenko I.G. The Treatment of Chlamydial Conjunctivitis. Basic Research. 2008. № 8. Pp 110-111.12. Maychuk Y.F. Modern Treatment of Conjunctivitis in Children. Pediatrics. App. to Joarnal «Consilium Medicum».  2007. № 2. Pp 80-87.13. Maychuk Y.F. Pharmacotherapy Conjunctivitis: a Great Choice. Russian Pharmacies. 2007. № 1. Pp. 28-30.14. Moiseev A.A. Treatment of Herpes Simplex with Synthetic Acyclic Nucleosides. BMIK Moses.  2014. №5. Pp.525.15. Approval of the Pharmaceutical Industry Development Strategy of the Russian Federation for the period up to 2020: The Order of Industry and Trade of the Russian Federation of 23.10.2009 number 965 - URL: http://www.consultant.ru/document/cons_doc_LAW_94066/ (date of access: August 15, 2016).16. The overall Incidence of the Adult Population of Russia in 2011: stat. materials. Part IV / Center. For Research of the Institute of Organization and Health Information Management; razrab .: G. A. Alexandrov, G. S. Lebedev, E. V. Ogryzko. - Moscow, 2012. URL: old.rosminzdrav.ru/docs/mzsr/stat/46/zd4.doc (date of access: August 15, 2016).17. Rublev O.V. On the Question of the Treatment and Prevention of Viral Infections. Polyclinic. 2012. № 4-1. Рр. 108-110.18. "Red-eye" Syndrome: Pract. Manual for Ophthalmologists / M. A.  Kovalevskaya, E. Yu Maychuk, V. V.  Brzhesky; ed. D. Y.  Maychuk. Moscow: B. I, 2010. 108 p.19. Comparative Characteristics of the Etiological Structure of Endogenous Anterior Uveitis in 1973-1997 and 2003-2004 / A.E. Babushkin, I.M. Kagirov, G.H. Zaynutdinova,  N.E. Shevchuk. The Problems of Ophthalmology. 2005. № 2. Pp 37-41.20. Tapalsky D.V., Boytsova N.Y., Dravitsa L.V.  Bactericidal Activity of Eye Drops Containing Fluorinated Quinolones. Health and Environmental Problems. 2014. № 1 (39). Pp. 107-110.